X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alzheimer's disease (87) 87
humans (76) 76
male (70) 70
dementia (68) 68
female (68) 68
index medicus (66) 66
aged (63) 63
neurology (63) 63
middle aged (59) 59
mild cognitive impairment (58) 58
neurosciences (47) 47
clinical neurology (35) 35
brain (32) 32
positron-emission tomography (32) 32
magnetic resonance imaging (29) 29
psychiatry (29) 29
positron emission tomography (28) 28
biomarkers (27) 27
aged, 80 and over (26) 26
alzheimer disease - diagnostic imaging (26) 26
alzheimer’s disease (20) 20
brain - diagnostic imaging (20) 20
alzheimers-disease (19) 19
fluorodeoxyglucose f18 (19) 19
national institute (19) 19
neuropsychological tests (18) 18
pet (18) 18
cognitive ability (17) 17
diagnosis (17) 17
alzheimers disease (15) 15
brain mapping (15) 15
diagnostic guidelines (15) 15
neurodegenerative diseases (15) 15
csf (14) 14
geriatrics & gerontology (14) 14
neuroimaging (14) 14
adult (13) 13
association workgroups (13) 13
fdg-pet (13) 13
metabolism (13) 13
pet imaging (13) 13
radiopharmaceuticals (13) 13
tomography (13) 13
alzheimer disease - cerebrospinal fluid (12) 12
alzheimer disease - metabolism (12) 12
cerebrospinal fluid (12) 12
medical and health sciences (12) 12
medicin och hälsovetenskap (12) 12
medicine & public health (12) 12
memory (12) 12
research (12) 12
alzheimer disease - pathology (11) 11
amyloid (11) 11
amyloid-beta (11) 11
dementia disorders (11) 11
disease progression (11) 11
functional connectivity (11) 11
image processing, computer-assisted (11) 11
mri (11) 11
pathology (11) 11
psychotherapy (11) 11
risk factors (11) 11
alzheimer disease - physiopathology (10) 10
aniline compounds (10) 10
cognition (10) 10
medical imaging (10) 10
mental disorders (10) 10
patients (10) 10
pittsburgh compound b (10) 10
prevalence (10) 10
radiology, nuclear medicine & medical imaging (10) 10
analysis (9) 9
atrophy (9) 9
brain - pathology (9) 9
case-control studies (9) 9
clinical medicine (9) 9
cortex (9) 9
genotype (9) 9
klinisk medicin (9) 9
neurologi (9) 9
nuclear medicine (9) 9
pib (9) 9
positron-emission tomography - methods (9) 9
thiazoles (9) 9
abridged index medicus (8) 8
age (8) 8
alzheimer disease - complications (8) 8
alzheimer disease - diagnosis (8) 8
alzheimer disease - genetics (8) 8
amyloid beta-peptides - metabolism (8) 8
article (8) 8
biomarker (8) 8
biomarkers - cerebrospinal fluid (8) 8
care and treatment (8) 8
disease (8) 8
follow-up studies (8) 8
medical research (8) 8
recommendations (8) 8
usage (8) 8
amyloid - metabolism (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Geriatrics Society, ISSN 0002-8614, 12/2018, Volume 66, Issue 12, pp. 2239 - 2240
Journal Article
DNP - Der Neurologe und Psychiater, ISSN 1616-2455, 9/2015, Volume 16, Issue 9, pp. 50 - 59
Die gegenwärtigen medikamentösen Behandlungsverfahren der Alzheimer-Krankheit beschränken sich auf das Stadium der Demenz und zielen auf eine Linderung der... 
Psychotherapy | Neurology | Medicine & Public Health | Psychiatry | Psychopharmacology
Journal Article
Neurology, ISSN 0028-3878, 04/2015, Volume 84, Issue 14, pp. 1392 - 1393
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 04/2017, Volume 58, Issue 4, p. 639
Knowledge about spatial and temporal patterns of β-amyloid (Aβ) accumulation is essential for understanding Alzheimer disease (AD) and for design of... 
Medical research | Brain | Medical imaging | Neurodegenerative diseases | Lewy body disease | Positron emission | Spatial discrimination | Clinical trials | Drug development | Substantia grisea | Accumulation | Lewy bodies | Mathematical analysis | Dementia disorders | β-Amyloid | Tomography | Alzheimers disease | Alzheimer's disease | Positron emission tomography
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 09/2014, Volume 15, Issue 13, pp. 1955 - 1960
Journal Article
The American Journal of Geriatric Psychiatry, ISSN 1064-7481, 02/2006, Volume 14, Issue 2, pp. 139 - 144
Although the clinical course of Alzheimer disease (AD) is gradual, it is useful for a number of reasons to distinguish between different levels of severity.... 
severity | CDR | staging | MMSE | Dementia | Severity | Staging | TESTS | PSYCHIATRY | NEUROPSYCHOLOGICAL ASSESSMENT | GERIATRICS & GERONTOLOGY | CONSORTIUM | ESTABLISH | VERSION | GERONTOLOGY | dementia | ALZHEIMERS-DISEASE CERAD | SCALE | REGISTRY | Alzheimer Disease - diagnosis | Neuropsychological Tests | Severity of Illness Index | Diagnosis, Differential | Humans | Female | Male | Aged
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2018, Volume 59, p. 504
Journal Article
Brain Connectivity, ISSN 2158-0014, 07/2016, Volume 6, Issue 6, pp. 435 - 447
The evolution of functional magnetic resonance imaging to resting state (R-fMRI) allows measurement of changes in brain networks attributed to state changes,... 
default mode | resting state | Baseline state | functional connectivity | neuronal activity | energy metabolism | Biomarkers - metabolism | Brain - metabolism | Magnetic Resonance Imaging | Humans | Middle Aged | Fluorodeoxyglucose F18 - metabolism | Glucose - metabolism | Female | Male | Positron-Emission Tomography | Brain Mapping - methods
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 01/2013, Volume 40, Issue 1, pp. 104 - 114
Journal Article
Therapeutische Umschau, ISSN 0040-5930, 04/2015, Volume 72, Issue 4, pp. 279 - 285
Journal Article
NeuroImage, ISSN 1053-8119, 01/2008, Volume 39, Issue 2, pp. 619 - 633
Journal Article
BMC Neurology, ISSN 1471-2377, 12/2019, Volume 19, Issue 1, pp. 1 - 6
Abstract Background As investigations of disease modifying drugs aim to slow down progression of Alzheimer’ disease (AD) biomarkers to reliably track disease... 
FDG-PET | Minimal sample size | Cortical thickness | PiB-PET | MRI | Effect size
Journal Article
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 05/2019, Volume 69, Issue 1, pp. 83 - 90
Cost- and time-effective markers of Alzheimer’s disease (AD), reliable and feasible at the population level are urgently needed. Soluble amyloid-β protein... 
Elderly people | Plasma | Dementia disorders | Biomarkers | Amyloid | Plasma levels | Cerebrospinal fluid | Elderly | Alzheimer's disease | Dementia | Geriatrics
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.